Cresco Labs (OTCMKTS:CRLBF) Rating Lowered to Hold at Atb Cap Markets

Atb Cap Markets cut shares of Cresco Labs (OTCMKTS:CRLBF) from a strong-buy rating to a hold rating in a report issued on Monday morning,Zacks.com reports. Atb Cap Markets also issued estimates for Cresco Labs’ FY2025 earnings at ($0.07) EPS.

A number of other equities research analysts also recently issued reports on the stock. Cormark downgraded shares of Cresco Labs from a “moderate buy” rating to a “hold” rating in a research report on Monday, November 11th. Roth Capital raised Cresco Labs to a “strong-buy” rating in a report on Sunday, November 10th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Cresco Labs in a report on Monday, August 12th. Four equities research analysts have rated the stock with a hold rating, two have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Cresco Labs has an average rating of “Moderate Buy” and a consensus target price of $2.50.

Cresco Labs Stock Down 3.8 %

Shares of OTCMKTS:CRLBF opened at $1.00 on Monday. The business’s 50 day moving average is $1.38 and its 200 day moving average is $1.57. Cresco Labs has a 12-month low of $1.00 and a 12-month high of $2.65. The stock has a market cap of $488.14 million, a price-to-earnings ratio of -5.00 and a beta of 1.73. The company has a quick ratio of 1.39, a current ratio of 1.97 and a debt-to-equity ratio of 1.80.

About Cresco Labs

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.